tricalcium phosphate has been researched along with alendronate in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.70) | 18.2507 |
2000's | 5 (13.51) | 29.6817 |
2010's | 27 (72.97) | 24.3611 |
2020's | 4 (10.81) | 2.80 |
Authors | Studies |
---|---|
Asplin, J; Bushinsky, DA; Krieger, NS; Neumann, KJ | 1 |
Ito, Y; Kohri, K; Okada, A; Senzaki, H; Tozawa, K; Yasui, T | 1 |
Burt, H; Duan, K; Duncan, CP; Garbuz, DS; Hu, Y; Kim, WY; Masri, BA; Oxland, TR; Wang, R | 1 |
Bigi, A; Bracci, B; Fini, M; Panzavolta, S; Torricelli, P | 2 |
Chazono, M; Kikuchi, T; Kitasato, S; Kumagae, Y; Marumo, K; Saito, M; Tanaka, T | 1 |
Hamamoto, S; Hirose, M; Itoh, Y; Kobayashi, T; Kohri, K; Okada, A; Tozawa, K; Yasui, T | 1 |
Bünger, C; Christensen, FB; Egund, N; Ji, Q; Li, HS; Lind, M; Xue, QY; Zou, XN | 1 |
Carlson, J; Gilligan, J; Ke, HZ; Kim, M; Li, J; Mehta, N; Murphy, K; Vignery, A; Zhang, Q | 1 |
Hwang, YS; Kim, CW; Kwon, IK; Lee, HJ; Lee, SC; Yun, YP | 1 |
Bo, W; Hai, T; Jindong, Z; Junchao, G; Li, B; Qiang, WB | 1 |
Bouler, JM; Bujoli, B; Despas, C; Fayon, F; Gauthier, O; Janvier, P; Khairoun, I; Massiot, D; Mellier, C; Montavon, G; Rouillon, T; Schnitzler, V; Walcarius, A | 1 |
Bigi, A; Boanini, E | 1 |
Hirose, M; Niimi, K; Yasui, T | 1 |
Chen, X; Gao, C; Gou, Z; Huang, R; Li, Z; Sun, X; Xia, W; Yang, G; Yang, X; Zhang, G | 1 |
Arai, K; Endo, N; Kondo, N; Netsu, T; Ogose, A | 1 |
Bigi, A; Boanini, E; Fini, M; Gazzano, M; Torricelli, P | 2 |
Eren, K; Ozdemir, H; Ozer, H; Toker, H | 1 |
Abo Hager, EA; Amin, G; El Shiekh, MA; Hazzaa, HH | 1 |
Shen, Z; Ye, J; Yu, T | 1 |
Li, G; Tang, H; Wang, J; Zhao, J | 1 |
Ding, CW; Li, JM; Li, YH; Wang, W; Wang, ZD; Zhang, HX | 1 |
Bigi, A; Boanini, E; Forte, L; Mihailescu, IN; Mihailescu, N; Pagani, S; Ristoscu, C; Torricelli, P | 1 |
Diba, M; Farbod, K; Harrington, MJ; Kentgens, AP; Leeuwenburgh, SC; Schmidt, S; Zinkevich, T | 1 |
Chu, W; Cui, S; Huang, Y; Liao, Y; Yan, M; Yang, C; Zhang, X; Zhao, C | 1 |
Albertini, B; Bigi, A; Campisi, B; Dolci, LS; Gandolfi, M; Panzavolta, S; Passerini, N | 1 |
Chen, DC; Cheng, Q; Hao, YQ; He, L; Hu, ZH; Liao, EY; Lin, H; Peng, YD; Song, CL; Tang, H; Wang, J; Wang, L; Wei, F; Xia, WB; You, L; Zhang, L; Zhang, ZL | 1 |
Gabbai-Armelin, PR; Jansen, JA; Lopez-Perez, PM; Renno, ACM; Ulrich, DJO; van den Beucken, JJJP; van Houdt, CIA | 1 |
Albertini, B; Bigi, A; Dolci, LS; Fini, M; Panzavolta, S; Passerini, N; Sicuro, L; Torricelli, P | 1 |
Abbadessa, A; Kucko, NW; Leeuwenburgh, SCG; Petre, DG; Polini, A; Vermonden, T | 1 |
Chowdhury, A; Karamched, SR; Nosoudi, N; Parasaram, V; Parrish, J; Siclari, S | 1 |
Bisso, S; Castagner, B; Couvreur, P; Leroux, JC; Mura, S | 1 |
Akiyama, S; Chazono, M; Inagaki, N; Kakuta, A; Kitasato, S; Komaki, H; Marumo, K; Tanaka, T | 1 |
Marcantonio, RAC; Molon, RS; Oliveira, GJPL; Prisinoto, NR; Scardueli, CR; Spin-Neto, R | 1 |
Chen, S; Cox, M; Eltit, F; Guo, Y; Wang, Q; Wang, R | 1 |
Choy, YB; Heo, CY; Jeong, J; Koo, BM; Shim, JH | 1 |
2 review(s) available for tricalcium phosphate and alendronate
Article | Year |
---|---|
[New therapy using bisphosphonate for urolithiasis].
Topics: Alendronate; Animals; Bed Rest; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Diphosphonates; Humans; Hypercalciuria; Osteoporosis; Time Factors; Urolithiasis | 2011 |
Bisphosphosphonate-calcium phosphate cement composite and its properties.
Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Drug Carriers; Drug Delivery Systems; Etidronic Acid; Humans; Pamidronate; Zoledronic Acid | 2019 |
1 trial(s) available for tricalcium phosphate and alendronate
Article | Year |
---|---|
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Topics: Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcifediol; Calcium Phosphates; China; Cholecalciferol; Female; Humans; Hypercalciuria; Middle Aged; Osteoporosis, Postmenopausal; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2018 |
34 other study(ies) available for tricalcium phosphate and alendronate
Article | Year |
---|---|
Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Topics: Alendronate; Animals; Bone Resorption; Calcium; Calcium Oxalate; Calcium Phosphates; Calcium, Dietary; Creatinine; Disease Models, Animal; Female; Humans; Kidney Calculi; Magnesium; Male; Phosphorus; Quaternary Ammonium Compounds; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley | 1999 |
Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model.
Topics: Agar; Alendronate; Animals; Calcium Oxalate; Calcium Phosphates; Cell Culture Techniques; Cells, Cultured; Crystallization; Diphosphonates; Dogs; Kidney; Osteopontin; Sialoglycoproteins; Urinary Calculi | 2004 |
Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Drug Therapy, Combination; Female; Osseointegration; Prostheses and Implants; Rabbits; Random Allocation; Tantalum | 2008 |
Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.
Topics: Alendronate; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Diphosphonates; Humans; Microscopy, Electron, Scanning; Osteoblasts; Osteoclasts; Pamidronate | 2009 |
Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Topics: Alendronate; Animals; Biocompatible Materials; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Dose-Response Relationship, Drug; Implants, Experimental; Osteoclasts; Osteogenesis; Rabbits | 2010 |
Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis.
Topics: Alendronate; Bone Density Conservation Agents; Calcium Phosphates; Female; Humans; Middle Aged; Osteoporosis; Postmenopause; Risk Factors; Urinary Calculi | 2009 |
Alendronate treatment does not inhibit bone formation within biphasic calcium phosphate ceramics in posterolateral spinal fusion: an experimental study in porcine model.
Topics: Alendronate; Animals; Calcium Phosphates; Ceramics; Female; Osteogenesis; Spinal Fusion; Swine | 2009 |
Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats.
Topics: Ablation Techniques; Alendronate; Animals; Biomechanical Phenomena; Bone Cements; Bone Density; Bone Marrow; Calcium Phosphates; Femur; Humans; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Inbred F344; Time Factors | 2010 |
In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.
Topics: Alendronate; Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorption; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Emulsions; Macrophages; Mice; Microscopy, Electron, Scanning; Microspheres; Osteoclasts; Particle Size; Solubility; Spectrometry, X-Ray Emission; Spectrophotometry, Atomic; Surface Properties; Thermography; X-Ray Diffraction | 2010 |
Functionalization of biomimetic calcium phosphate bone cements with alendronate.
Topics: Adult; Alendronate; Biomimetic Materials; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Humans; Immunoassay; Interleukin-6; Leukocytes, Mononuclear; Microscopy, Electron, Scanning; Osteoblasts; Osteocalcin | 2010 |
Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.
Topics: Alendronate; Animals; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Cell Proliferation; Disease Models, Animal; Drug Delivery Systems; Materials Testing; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Osteoporosis; Rats; Spectroscopy, Fourier Transform Infrared | 2010 |
Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.
Topics: Adsorption; Alendronate; Apatites; Bone Cements; Calcium Phosphates; Dielectric Spectroscopy; Diphosphonates; Hip Fractures; Imidazoles; Magnetic Resonance Spectroscopy; Osteoporotic Fractures; Time Factors; Zoledronic Acid | 2011 |
Biomimetic gelatin-octacalcium phosphate core-shell microspheres.
Topics: Alendronate; Biomimetics; Bone Substitutes; Calcium Phosphates; Gelatin; Microspheres; Regenerative Medicine; Tissue Engineering | 2011 |
Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals.
Topics: Alendronate; Biomimetic Materials; Bone and Bones; Bone Density Conservation Agents; Calcium Phosphates; Cetrimonium; Cetrimonium Compounds; Durapatite; Micelles; Models, Biological; Nanoparticles; Phase Transition; Surface-Active Agents; Time Factors | 2012 |
Osteoconductive action of alendronate after implantation of beta tricalcium phosphate in rat adjuvant-induced arthritis.
Topics: Acid Phosphatase; Alendronate; Animals; Arthritis, Experimental; Calcification, Physiologic; Calcium Phosphates; Collagen Type I; Collagen Type I, alpha 1 Chain; Isoenzymes; Male; Osteocalcin; Osteogenesis; Rats; Tartrate-Resistant Acid Phosphatase | 2012 |
The effect of alendronate doped calcium phosphates on bone cells activity.
Topics: Alendronate; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Coculture Techniques; Diphosphonates; Durapatite; Humans; Microscopy, Electron, Scanning; Osteoblasts; Osteoclasts; X-Ray Diffraction | 2012 |
A comparative evaluation of the systemic and local alendronate treatment in synthetic bone graft: a histologic and histomorphometric study in a rat calvarial defect model.
Topics: Alendronate; Analysis of Variance; Animals; Bone Density Conservation Agents; Bone Resorption; Bone Transplantation; Calcium Phosphates; Histological Techniques; Male; Models, Animal; Osteoblasts; Osteoclasts; Osteogenesis; Rats; Rats, Wistar; Skull | 2012 |
Crystalline calcium alendronate obtained by octacalcium phosphate digestion: a new chance for local treatment of bone loss diseases?
Topics: Alendronate; Bone Resorption; Calcium; Calcium Phosphates; Cell Differentiation; Cell Proliferation; Crystallization; Humans; Models, Molecular; Osteoblasts; Particle Size; Structure-Activity Relationship; Surface Properties | 2013 |
Influence of alendronate administration regimen on the final outcome of implant osseointegration in an osteoporotic model.
Topics: Alendronate; Animals; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Dexamethasone; Disease Models, Animal; Female; Femur; Implants, Experimental; Osseointegration; Osteoporosis; Prospective Studies; Rabbits | 2014 |
Microstructure and properties of alendronate-loaded calcium phosphate cement.
Topics: Alendronate; Analysis of Variance; Bone Cements; Calcium Phosphates; Materials Testing; Porosity; Rheology; Viscosity | 2014 |
Local treatment of osteoporosis with alendronate-loaded calcium phosphate cement.
Topics: Alendronate; Animals; Bone Cements; Bone Density; Calcium Phosphates; Female; Osteoporosis; Rats; Rats, Sprague-Dawley | 2014 |
The biocompatibility of calcium phosphate cements containing alendronate-loaded PLGA microparticles in vitro.
Topics: Alendronate; Animals; Biocompatible Materials; Bone and Bones; Bone Cements; Calcium Phosphates; Cell Adhesion; Cell Cycle; Cell Differentiation; Cell Proliferation; Compressive Strength; Flow Cytometry; Lactic Acid; Male; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Tissue Engineering; Tissue Scaffolds | 2015 |
Antiresorption implant coatings based on calcium alendronate and octacalcium phosphate deposited by matrix assisted pulsed laser evaporation.
Topics: Alendronate; Calcium Phosphates; Coated Materials, Biocompatible; Coculture Techniques; Humans; Lasers; Osteoblasts; Osteoclasts; Powder Diffraction | 2015 |
Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate.
Topics: Alendronate; Bone Regeneration; Calcification, Physiologic; Calcium Phosphates; Drug Delivery Systems; Drug Liberation; Gelatin; Glutaral; Humans; Materials Testing; Nanoparticles; Particle Size | 2016 |
Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Calcium Phosphates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Durapatite; Female; Humans; Methotrexate; Mice; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement.
Topics: Alendronate; Biocompatible Materials; Bone Cements; Calcium Phosphates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diphosphonates; Drug Carriers; Drug Delivery Systems; Lipids; Materials Testing; Microscopy, Electron, Scanning; Particle Size; Polymers; X-Ray Diffraction | 2018 |
Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions.
Topics: Alendronate; Animals; Bone Cements; Bone Density Conservation Agents; Bone Regeneration; Calcium Phosphates; Female; Materials Testing; Osteogenesis; Osteoporosis; Polyglycolic Acid; Rats; Rats, Wistar | 2018 |
Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast-osteoclast co-culture study.
Topics: Alendronate; Biomimetic Materials; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Cell Differentiation; Cell Survival; Chemistry, Pharmaceutical; Coculture Techniques; Delayed-Action Preparations; Drug Liberation; Humans; Lipids; Microspheres; Osteoblasts; Osteoclasts | 2019 |
Surface functionalization of polylactic acid fibers with alendronate groups does not improve the mechanical properties of fiber-reinforced calcium phosphate cements.
Topics: Aldehydes; Alendronate; Biocompatible Materials; Bone Cements; Calcium Phosphates; Durapatite; Materials Testing; Mechanical Phenomena; Polyesters; Surface Properties | 2019 |
Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles.
Topics: Alendronate; Animals; Calcium Phosphates; Cell Line; Cell Line, Tumor; Diphosphonates; DNA; Drug Delivery Systems; Female; Genetic Therapy; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Nucleic Acids; Permeability; Plasmids; Polyethylene Glycols; Transfection | 2019 |
Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Resorption; Calcium Phosphates; Female; Humans; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Alendronate Impairs Healing of Calvaria Critical Defects After Bone Graft With Different Bone Substitute Materials.
Topics: Alendronate; Animals; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Cattle; Rats; Skull; Transplants; X-Ray Microtomography | 2020 |
An Ammonia-Induced Calcium Phosphate Nanostructure: A Potential Assay for Studying Osteoporosis and Bone Metastasis.
Topics: Alendronate; Ammonia; Animals; Bone and Bones; Calcium Phosphates; Cell Differentiation; Drug Carriers; Humans; Membranes, Artificial; Mice; Nanostructures; Osteoclasts; Osteoporosis; PC-3 Cells; Porosity; RAW 264.7 Cells | 2021 |
Synergistic Effect of Whitlockite Scaffolds Combined with Alendronate to Promote Bone Regeneration.
Topics: Alendronate; Animals; Bone Regeneration; Calcium Phosphates; Humans; Mice; Osteogenesis | 2022 |